MedTrace Logo

Observational Study of Baska Mask, a New Supraglottic Airway Device

NCT01496859 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2012-03-26

No results posted yet for this study

Summary

The Baska mask is a new supraglottic airway device . The investigators would like to assess its performance in setting in which the current standard - LMA device - is being used.

Conditions

  • Performance and Safety of a New Supraglottic Airway Device

Interventions

DEVICE

Placement and use of Baska mask

use of a supraglottic airway device as a standard part of a general anaesthetic

Sponsors & Collaborators

  • University College Hospital Galway

    lead OTHER

Principal Investigators

  • John G Laffey, FFARCSI · National University of Ireland, Galway and Galway University Hospitals

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01496859 on ClinicalTrials.gov